Sarepta Therapeutics, Inc. Purchase Agreements
10 Contracts & Agreements
- Purchase Agreement, dated as of September 13, 2022, between Sarepta Therapeutics, Inc. and Michael A. Chambers Living Trust (Filed With SEC on September 19, 2022)
- Purchase Agreement, dated as of September 13, 2022, among Sarepta Therapeutics, Inc. and the several Initial Purchasers named in Schedule 1 thereto for whom Goldman, Sachs & Co.... (Filed With SEC on September 19, 2022)
- Purchase Agreement, dated as of November 8, 2017, among Sarepta Therapeutics, Inc. and the several Initial Purchasers named in Schedule 1 thereto for whom J.P. Morgan Securities... (Filed With SEC on November 14, 2017)
- Asset Purchase Agreement dated February 20, 2017 by and between Sarepta Therapeutics Inc. and Gilead Sciences, Inc (Filed With SEC on May 4, 2017)
- SAREPTA THERAPEUTICS, INC. AMENDED AND RESTATED 2013 EMPLOYEE STOCK PURCHASE PLAN (as Amended and Restated on June 27, 2016) Sarepta Therapeutics, Inc., a Delaware corporation... (Filed With SEC on July 1, 2016)
- PURCHASE AND SALE AGREEMENT (Filed With SEC on August 7, 2014)
- Form of 2004 Purchase Warrant AVI BIOPHARMA, INC. WARRANT (Filed With SEC on January 29, 2004)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 8, 2003)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 9, 2003)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 7, 2003)